No mutations in the CYLD gene were identified in T-ALL patients, indicating that in contrast to the multiple myeloma setting, where CYLD mutations were detected [29,30], this gene is inhibited at the transcriptional level. This evidence concerns the gene CYLD and acute lymphoblastic leukemia.